As of Wednesday close, Merck & Co. Inc.’s (NYSE:MRK) stock was down -$0.08, moving down -0.07 percent to $106.82. The average number of shares traded per day over the past five days has been 8,614,540 shares. 5 times new highs have been achieved over the past 5 days, with a $6.89 gain in that time frame. In the last twenty days, the average volume was 9,663,516, while in the previous 50 days, it was 9,318,192.
Since last month, MRK stock rose 9.32%. Shares of the company fell to $96.27 on 10/24/22, the lowest level in the past month. A 52-week high of $107.10 was reached on 11/23/22 after having rallying from a 52-week low of $71.50. Since the beginning of this year, MRK’s stock price has risen by 39.38% or $30.18, and marked a new high 33 times. However, the stock has declined by -0.26% since its 52-week high.
Do You Own These 7 Inflation-Survival Stocks?
Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.
Click here to get your free copy of the report
MRK stock investors should be aware that Merck & Co. Inc. (MRK) stock had its last reported insider trading activity 15 days ago on Nov 10. MIZELL STEVEN, the EVP, Chief HR Officer of the company, disposed of 15,000 shares for $101.42 on Nov 10. It resulted in a $1,521,278 divestment by the insider. Oosthuizen Johannes Jacobus sold 1,795 shares at an average price of $103.21 on Nov 09. The insider now owns 16,731 shares following the transaction. On Nov 09, CEO & President Davis Robert M sold 167,613 shares at $102.44 apiece. The transaction was valued at $17,169,840.
Right now, Merck & Co. Inc. (MRK) has a P/E ratio of about 17.70. The stock’s beta is 0.40. Besides these, the trailing price-to-sales (P/S) ratio of 4.51, the price-to-book (PB) ratio of 6.09, and the price-to-cash flow ratio of 31.86 may also be considered.
The latest dividend of $0.69 per share was paid out, remained unchanged from last year’s $0.69. On Tuesday November 30 2021, a $0.04 dividend increase was announced.
In the three months ended September 29, Merck & Co. Inc.’s quick ratio stood at 1.20, while its current ratio was 1.50, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending September 29 was 0.64, and the total debt-to-equity ratio was 0.68. On the profitability front, the trailing twelve-month gross margin is 70.90% percent. In the year ended September 29, operating margins totaled 30.70%. Based on annual data, MRK earned $35.08 billion in gross profit and brought in $48.7 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 15.50%. Return on equity (ROE) for the past 12 months was 36.60%.
In Merck & Co. Inc.’s quarter-end financial report for September 29, it reported total debt of $28.48 billion against cash and short-term investments of $103.0 million. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. MRK’s revenue rose 12.07% to $14.59 billion during the quarter, while net income inched up to $14.96 billion. While analysts expected Merck & Co. Inc. to report $1.71 quarterly earnings, the actual figure was $1.85 per share, beating the consensus estimate by 8.20%. During the quarter, the company generated $5.07 billion in EBITDA. The liabilities of Merck & Co. Inc. were 62.56 billion at the end of its most recent quarter ended September 29, and its total debt was $31.66 billion. The value of shareholders’ equity is $2.54 billion.
This quick technical analysis looks at Merck & Co. Inc.’s (MRK) price momentum. With a historical volatility rate of 29.47%, the RSI 9-day stood at 76.11% on 23 November.
With respect to its five-day moving average, the current Merck & Co. Inc. price is up by +6.89% percent or $6.89. At present, MRK shares trade +8.55% above its 20-day simple moving average and +15.31% percent above its 100-day simple moving average. However, the stock is currently trading approximately +22.85% above its SMA50 and +38.89% above its SMA200.
Stochastic coefficient K was 96.70% and Stochastic coefficient D was 94.36%, while ATR was 2.07. Given the Stochastic reading of 95.19% for the 14-day period, the RSI (14) reading has been calculated as 73.15%. As of today, the MACD Oscillator reading stands at 3.81, while the 14-day reading stands at 4.45.